Brendan P. Rae

Brendan P. Rae

Corporate Officer/Principal chez
New York Medical College
Health Technology
Consumer Services
Retail Trade

Profil

Brendan P.
Rae
is an Adjunct Assistant Professor at New York Medical College since 1989.
He was previously an Executive Director at NPS Pharmaceuticals, Inc. from 2014 to 2015, a Senior Director-Licensing & Business Development at Purdue Pharma LP from 2003 to 2005, a Vice President-Business Development at VIA Pharmaceuticals, Inc. from 2005 to 2007, a Senior Vice President-Business Development at VIA Pharmaceuticals, Inc. from 2005 to 2010, a Chief Business Officer at Vivaldi Biosciences, Inc. from 2010 to 2011, a Chief Business Officer at Serina Therapeutics, Inc., and a Senior Vice President-Business Development at CytoDyn, Inc. He obtained his undergraduate and doctorate degrees from the University of Glasgow and his graduate degree from Seton Hall University School of Law.
Currently, Dr. Rae is an Adjunct Assistant Professor at New York Medical College.

Postes actifs de Brendan P. Rae

SociétésPosteDébut
Corporate Officer/Principal 01/01/1989

Anciens postes connus de Brendan P. Rae

SociétésPosteFin
NPS PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/12/2015
Corporate Officer/Principal 01/11/2011
VIA PHARMACEUTICALS, INC. Corporate Officer/Principal 01/04/2010
Corporate Officer/Principal 07/06/2007
Corporate Officer/Principal 01/01/2005
Voir l'expérience en détail de Brendan P. Rae

Formation de Brendan P. Rae

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

73

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Consumer Services

Distribution Services

Consumer Services

Health Technology

Commercial Services

Consumer Services

  1. Bourse
  2. Insiders
  3. Brendan P. Rae
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT